Sensitization of tumour cells to lysis by virus-specific CTL using antibody-targeted MHC class I/peptide complexes
Open Access
- 1 March 2000
- journal article
- Published by Springer Nature in British Journal of Cancer
- Vol. 82 (5) , 1058-1062
- https://doi.org/10.1054/bjoc.1999.1042
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Quantitation of HIV-1-Specific Cytotoxic T Lymphocytes and Plasma Load of Viral RNAScience, 1998
- Phenotypic Analysis of Antigen-Specific T LymphocytesScience, 1996
- Allograft survival following immunization with membrane-bound or soluble peptide MHC class I donor antigens: factors relevant for the induction of rejection by indirect recognitionTransplant International, 1996
- Superantigen‐induced cytokines suppress growth of human colon‐carcinoma cellsInternational Journal of Cancer, 1993
- Monoclonal antibodies in the detection and therapy of micrometastatic epithelial cancersCurrent Opinion in Immunology, 1992
- A phase‐i study of repeated therapy with radiolabelled antibody to carcinoembryonic antigen using intermittent or continuous administration of cyclosporin a to suppress the immune responseInternational Journal of Cancer, 1991
- Antigen Recognition by Class I-Restricted T LymphocytesAnnual Review of Immunology, 1989
- SOLUBLE HLA ANTIGENS IN THE CIRCULATION OF LIVER GRAFT RECIPIENTSTransplantation, 1989
- Inhibition of an allospecific T cell hybridoma by soluble class I proteins and peptides: Estimation of the affinity of a T cell receptor for MHCCell, 1988
- Specific targeting of cytotoxic T cells by anti-T3 linked to anti-target cell antibodyNature, 1985